Cargando…

Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome

BACKGROUND: Fragile X syndrome (FXS) is the leading cause of inheritable intellectual disability in male children, and is predominantly caused by a single gene mutation resulting in expanded trinucleotide CGG-repeats within the 5’ untranslated region of the fragile X mental retardation (FMR1) gene....

Descripción completa

Detalles Bibliográficos
Autores principales: Careaga, Milo, Noyon, Tamanna, Basuta, Kirin, Van de Water, Judy, Tassone, Flora, Hagerman, Randi J, Ashwood, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107617/
https://www.ncbi.nlm.nih.gov/pubmed/24942544
http://dx.doi.org/10.1186/1742-2094-11-110
_version_ 1782327626804756480
author Careaga, Milo
Noyon, Tamanna
Basuta, Kirin
Van de Water, Judy
Tassone, Flora
Hagerman, Randi J
Ashwood, Paul
author_facet Careaga, Milo
Noyon, Tamanna
Basuta, Kirin
Van de Water, Judy
Tassone, Flora
Hagerman, Randi J
Ashwood, Paul
author_sort Careaga, Milo
collection PubMed
description BACKGROUND: Fragile X syndrome (FXS) is the leading cause of inheritable intellectual disability in male children, and is predominantly caused by a single gene mutation resulting in expanded trinucleotide CGG-repeats within the 5’ untranslated region of the fragile X mental retardation (FMR1) gene. Reports have suggested the presence of immune dysregulation in FXS with evidence of altered plasma cytokine levels; however, no studies have directly assessed functional cellular immune responses in children with FXS. In order to ascertain if immune dysregulation is present in children with FXS, dynamic cellular responses to immune stimulation were examined. METHODS: Peripheral blood mononuclear cells (PBMC) were from male children with FXS (n = 27) and from male aged-matched typically developing (TD) controls (n = 8). PBMC were cultured for 48 hours in media alone or with lipopolysaccharides (LPS; 1 μg/mL) to stimulate the innate immune response or with phytohemagglutinin (PHA; 8 μg/mL) to stimulate the adaptive T-cell response. Additionally, the group I mGluR agonist, DHPG, was added to cultures to ascertain the role of mGluR signaling in the immune response in subject with FXS. Supernatants were harvested and cytokine levels were assessed using Luminex multiplexing technology. RESULTS: Children with FXS displayed similar innate immune response following challenge with LPS alone when compared with TD controls; however, when LPS was added in the presence of a group I mGluR agonist, DHPG, increased immune response were observed in children with FXS for a number of pro-inflammatory cytokines including IL-6 (P = 0.02), and IL-12p40 (P < 0.01). Following PHA stimulation, with or without DHPG, no significant differences between subjects with FXS and TD were seen. CONCLUSIONS: In unstimulated cultures, subjects with FXS did not display altered dynamic immune response to LPS or PHA alone; however, subjects with FXS showed an altered response to co-current stimulation of LPS and DHPG, such that subjects with FXS failed to inhibit production of pro-inflammatory cytokines, suggesting a role of group I mGluR signaling in innate immune responses in FXS.
format Online
Article
Text
id pubmed-4107617
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41076172014-07-24 Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome Careaga, Milo Noyon, Tamanna Basuta, Kirin Van de Water, Judy Tassone, Flora Hagerman, Randi J Ashwood, Paul J Neuroinflammation Research BACKGROUND: Fragile X syndrome (FXS) is the leading cause of inheritable intellectual disability in male children, and is predominantly caused by a single gene mutation resulting in expanded trinucleotide CGG-repeats within the 5’ untranslated region of the fragile X mental retardation (FMR1) gene. Reports have suggested the presence of immune dysregulation in FXS with evidence of altered plasma cytokine levels; however, no studies have directly assessed functional cellular immune responses in children with FXS. In order to ascertain if immune dysregulation is present in children with FXS, dynamic cellular responses to immune stimulation were examined. METHODS: Peripheral blood mononuclear cells (PBMC) were from male children with FXS (n = 27) and from male aged-matched typically developing (TD) controls (n = 8). PBMC were cultured for 48 hours in media alone or with lipopolysaccharides (LPS; 1 μg/mL) to stimulate the innate immune response or with phytohemagglutinin (PHA; 8 μg/mL) to stimulate the adaptive T-cell response. Additionally, the group I mGluR agonist, DHPG, was added to cultures to ascertain the role of mGluR signaling in the immune response in subject with FXS. Supernatants were harvested and cytokine levels were assessed using Luminex multiplexing technology. RESULTS: Children with FXS displayed similar innate immune response following challenge with LPS alone when compared with TD controls; however, when LPS was added in the presence of a group I mGluR agonist, DHPG, increased immune response were observed in children with FXS for a number of pro-inflammatory cytokines including IL-6 (P = 0.02), and IL-12p40 (P < 0.01). Following PHA stimulation, with or without DHPG, no significant differences between subjects with FXS and TD were seen. CONCLUSIONS: In unstimulated cultures, subjects with FXS did not display altered dynamic immune response to LPS or PHA alone; however, subjects with FXS showed an altered response to co-current stimulation of LPS and DHPG, such that subjects with FXS failed to inhibit production of pro-inflammatory cytokines, suggesting a role of group I mGluR signaling in innate immune responses in FXS. BioMed Central 2014-06-19 /pmc/articles/PMC4107617/ /pubmed/24942544 http://dx.doi.org/10.1186/1742-2094-11-110 Text en Copyright © 2014 Careaga et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Careaga, Milo
Noyon, Tamanna
Basuta, Kirin
Van de Water, Judy
Tassone, Flora
Hagerman, Randi J
Ashwood, Paul
Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome
title Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome
title_full Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome
title_fullStr Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome
title_full_unstemmed Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome
title_short Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome
title_sort group i metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile x syndrome
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107617/
https://www.ncbi.nlm.nih.gov/pubmed/24942544
http://dx.doi.org/10.1186/1742-2094-11-110
work_keys_str_mv AT careagamilo groupimetabotropicglutamatereceptormediateddynamicimmunedysfunctioninchildrenwithfragilexsyndrome
AT noyontamanna groupimetabotropicglutamatereceptormediateddynamicimmunedysfunctioninchildrenwithfragilexsyndrome
AT basutakirin groupimetabotropicglutamatereceptormediateddynamicimmunedysfunctioninchildrenwithfragilexsyndrome
AT vandewaterjudy groupimetabotropicglutamatereceptormediateddynamicimmunedysfunctioninchildrenwithfragilexsyndrome
AT tassoneflora groupimetabotropicglutamatereceptormediateddynamicimmunedysfunctioninchildrenwithfragilexsyndrome
AT hagermanrandij groupimetabotropicglutamatereceptormediateddynamicimmunedysfunctioninchildrenwithfragilexsyndrome
AT ashwoodpaul groupimetabotropicglutamatereceptormediateddynamicimmunedysfunctioninchildrenwithfragilexsyndrome